Disease surveillance Study Guide

📖 Core Concepts Disease Surveillance – Ongoing systematic collection, analysis, and interpretation of health data to monitor disease spread, predict outbreaks, and reduce harm. Case Reporting – Hospitals submit numbers of diagnosed cases; data are collated and made public, often within hours thanks to modern communication. Incidence Counts – Number of new cases in a defined period; used as health indicators of population wellbeing. Notifiable Diseases – Specific infectious agents that health‑care providers must report to authorities (e.g., TB, HIV, botulism, anthrax, rabies). Public‑Health Surveillance – Broader term encompassing disease surveillance plus data use for planning, implementing, and evaluating public‑health actions. World Health Organization (WHO) Role – Global coordinator for disease response; runs Epidemic and Pandemic Alert & Response (EPR) program, disease‑specific websites, and field teams. Contact Tracing – Identifying and notifying individuals who have been exposed to a confirmed case. Predictive Analytics – Statistical techniques that turn existing data into forecasts of future disease events. Early Warning & Response Systems – Networks (e.g., European EWR) that rapidly share communicable‑disease information across regions. --- 📌 Must Remember Surveillance predicts, observes, and minimizes outbreak harm. Modern tech enables case/death reports within days or hours. About 80 notifiable diseases are tracked in the United States. WHO requires national governments to monitor notifiable infectious agents. EPR program: rapid detection → verification → response to epidemic‑prone threats. Cost of diagnostic testing and antibody cross‑reactivity are major technical limits. Pandemic‑preparedness window for a novel flu strain: 2–3 weeks from first human cases. The Council of State and Territorial Epidemiologists (CSTE) sets U.S. surveillance standards. --- 🔄 Key Processes Case Reporting Workflow Clinician diagnoses → hospital records case → reports to local health department → data aggregated nationally → public release. WHO Outbreak Alert & Response Country detects unusual event → notifies WHO → WHO verifies → alerts network → deploys field teams / resources. Contact Tracing Steps Identify index case → list all recent contacts → reach out & assess exposure → advise testing/quarantine → monitor outcomes. Predictive Analytics Cycle Gather historic incidence → apply statistical model → generate forecast → validate against new data → inform preparedness actions. Early Warning System Communication Regional labs detect signal → feed into central database → algorithm flags anomaly → automated alerts sent to member countries. --- 🔍 Key Comparisons Disease Surveillance vs. Public‑Health Surveillance – Surveillance focuses on monitoring disease spread; public‑health surveillance adds planning & evaluating interventions. Notifiable Disease List (U.S.) vs. International WHO List – U.S. list (80 diseases) is broader; WHO list includes globally priority agents and mandates reporting to the organization. Contact Tracing vs. Early Warning Systems – Tracing is individual‑level (who contacted whom); early warning is population‑level (spike in incidence across regions). --- ⚠️ Common Misunderstandings “Surveillance = only data collection.” It also drives action (prediction, response). “All diseases are notifiable.” Only designated infectious agents must be reported. “High incidence always means a bad health status.” Incidence may rise due to improved detection rather than worsening disease. “WHO can instantly stop an outbreak.” WHO can coordinate and alert, but containment depends on national capacity and resources. --- 🧠 Mental Models / Intuition Surveillance as a “radar screen.” Continuous blips (case reports) appear; the goal is to spot a new, growing cluster before it becomes a storm. Cost & Cross‑reactivity as “static.” They obscure the true signal, requiring louder (more expensive) testing or smarter assays to clear the picture. --- 🚩 Exceptions & Edge Cases Resource‑limited countries may skip expensive diagnostic tests → under‑reporting. Antibody cross‑reactivity can misclassify exposure to related strains, leading to false‑positive alerts. Reporting delays (beyond the 2–3‑week window) can let a pandemic strain spread unchecked. --- 📍 When to Use Which Use case reporting when you need real‑time counts for immediate response. Deploy predictive analytics when historic trends exist and you must forecast future burden. Apply contact tracing for confirmed cases of a disease with person‑to‑person spread. Activate early warning systems when a regional surge is detected but individual cases are not yet confirmed. --- 👀 Patterns to Recognize Sudden, multi‑source rise in incidence across hospitals → possible outbreak. Consistent under‑reporting from low‑resource settings → look for cost‑related gaps. Parallel antibody signals that overlap multiple strains → suspect cross‑reactivity. Delay > 2 weeks from first human case to WHO notification → high pandemic risk. --- 🗂️ Exam Traps Distractor: “Surveillance only involves passive data collection.” – Wrong; active verification and rapid response are integral. Distractor: “All infectious diseases are on the notifiable list.” – Incorrect; only designated agents must be reported. Distractor: “WHO’s EPR program deals exclusively with influenza.” – Misleading; EPR addresses any epidemic‑prone or emerging disease. Distractor: “High incidence automatically triggers a public‑health emergency.” – Not always; must consider testing capacity, reporting completeness, and context.